is it okay to switch from semaglutide to tirzepatide Understand the Difference between and Tirzepatide vs. Semaglutide for Weight

This is not a formally documented adverse effect in the Summary of Product Characteristics (SmPC) but may reflect individual susceptibility or coincidental dermatological conditions

contact your prescriber for instructions on adjusted dosing or vial replacement

Triple-Hormone-Receptor Agonist Retatrutide for Obesity Phase 2 Trial

Lyophilized IGF-1 LR3 remains stable for 24+ months at 20C and tolerates brief ambient temperature exposure during shipping without significant potency loss

Nausea Vomiting Heartburn Abdominal discomfort Diarrhea Constipation Bloating Indigestion Burping Fatigue Headache Mild redness, itching, or soreness at the injection site Less Common but Important Risks Gallbladder disease or gallstones requiring removal of gallbladder Delayed stomach emptying (gastroparesis) Pancreatitis Kidney Considerations Severe dehydration related to persistent vomiting or diarrhea may increase the risk of acute kidney injury